European consensus statement on the terminology used in the management of lupus glomerulonephritis
Caroline Gordon(University of Birmingham), G. R. V. Hughes(Hammersmith Hospital), Falk Hiepe(Leibniz Association), Carlos Vasconcelos(Hospital de Santo António), Frédéric Houssiau(Cliniques Universitaires Saint-Luc), Pier Luigi Meroni(IRCCS Istituto Auxologico Italiano), Ricard Cervera(Hospital Clínic de Barcelona), Jaime Calvo‐Alén(Hospital Sierrallana), J Ballerin(Puigvert Foundation), Andrea Doria(University of Padua), Manuel Praga(Universidad Complutense de Madrid), Dwomoa Adu, Marion Haubitz(Klinikum Fulda), Franco Ferrario(Ospedale San Carlo), David Jayne(University of Cambridge), Carlo Chizzolini(University of Geneva), Hendrik Schulze‐Koops(LMU Klinikum), Anǵela Tincani(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Loı̈c Guillevin(Unknown), Charles D. Pusey(Imperial College Healthcare NHS Trust), Martin Aringer(University Hospital Carl Gustav Carus), Jürgen Floege(Westfälische Hochschule), Ra Sinico(Azienda Ospedaliera Ospedale San Carlo Borromeo), J-M Dayer(University of Geneva), P Lesavre(Hôpital Necker-Enfants Malades), Olivier Meyer(Hôpital Bichat-Claude-Bernard), Z. Amoura(Sorbonne Université), Bruno Moulin(Université de Strasbourg), K. O'Reilly, Liz Lightstone(Imperial College London)
Cited by 150
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
|New England Journal of Medicine|2010|1.7k
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
|Annals of the Rheumatic Diseases|2019|1.5k